MBX Biosciences, Inc. - Common Stock (MBX)

44 filings reported holding MBX - MBX Biosciences, Inc. - Common Stock as of Q3 2024.
MBX Biosciences, Inc. - Common Stock (MBX) has 44 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 30.3M shares of 44.7M outstanding shares and own 67.8% of the company stock.
Largest 10 shareholders include Frazier Life Sciences Management, L.P. (5.99M shares), ORBIMED ADVISORS LLC (3.81M shares), NEA Management Company, LLC (3.61M shares), Deep Track Capital, LP (3.02M shares), WELLINGTON MANAGEMENT GROUP LLP (2.94M shares), NVP Associates, LLC (2.14M shares), RA CAPITAL MANAGEMENT, L.P. (1.51M shares), PRICE T ROWE ASSOCIATES INC /MD/ (1.19M shares), EcoR1 Capital, LLC (1.18M shares), and Driehaus Capital Management LLC (981K shares).
This table shows the top 44 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.